How is the pulmonary-to-systemic flow ratio (Qp/Qs) measured by echocardiography in a ventricular septal defect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

How to Measure Qp/Qs in Ventricular Septal Defect by Echocardiography

Qp/Qs in VSD is measured by Doppler echocardiography using the ratio of left ventricular inflow volume (LVIV) to left ventricular outflow volume (LVOV), though this method is prone to inaccuracy and CMR is now the preferred non-invasive reference standard.

Echocardiographic Technique

The most validated echocardiographic approach involves calculating the ratio LVIV/LVOV 1:

Step-by-Step Measurement

Left Ventricular Outflow Volume (LVOV):

  • Measure the left ventricular outflow tract (LVOT) diameter immediately proximal to the aortic valve ring
  • Obtain pulsed Doppler velocity time integral (VTI) of ejection flow in the LVOT
  • Calculate: LVOV = (π × [LVOT diameter/2]²) × VTI × heart rate

Left Ventricular Inflow Volume (LVIV):

  • Measure transmitral flow velocity using pulsed Doppler
  • Trace mitral valve motion on M-mode echocardiography to determine mitral annulus area
  • Calculate: LVIV = mitral annulus area × transmitral VTI × heart rate

Qp/Qs Calculation:

  • Qp/Qs = LVIV/LVOV
  • Normal value: 0.97 ± 0.1
  • VSD patients typically show LVIV/LVOV of 1.87 ± 0.88 2, 3

Alternative Echocardiographic Methods

Four different Doppler methods exist, though with varying accuracy 4:

  1. Volume flow method: Calculate pulmonary artery and aortic flow using VTI and luminal areas (r = 0.54-0.66 with catheterization)

  2. Velocity ratio method: (PA diameter/Ao diameter)² × (PA peak velocity/Ao peak velocity)

  3. Four-valve method: Include mitral and tricuspid valve flows with great vessel flows

  4. Direct VSD flow method: Calculate shunt flow directly from VSD diameter and VTI, then add to aortic flow (r = 0.82-0.90 with catheterization) 4

The direct VSD flow method shows the best correlation with invasive measurements, particularly for defects <9 mm/m².

Critical Limitations and Pitfalls

Why Echocardiography Falls Short

The 2022 multi-society guidelines explicitly state that "echocardiographic evaluation of shunt magnitude is prone to inaccuracy due to inadequate data acquisition and invalid assumptions in the calculation" 1. Key problems include:

  • Operator dependence: Requires precise angle alignment and measurement technique
  • Acoustic window limitations: Particularly problematic in older patients and adults
  • Geometric assumptions: Assumes circular vessel cross-sections and laminar flow
  • Valve competence requirement: Accuracy depends on competent AV and semilunar valves 1
  • Multiple measurements: Error propagates through multiple required measurements

When Echocardiography is Insufficient

Consider alternative imaging when:

  • Qp/Qs measurement is critical for surgical decision-making
  • Patient has poor acoustic windows
  • Precise quantification needed (e.g., borderline surgical candidates)
  • Complex or multiple VSDs present 1

The Superior Alternative: CMR

CMR using phase-contrast imaging (PC-CMR) has become the non-invasive reference standard for Qp/Qs measurement 1. PC-CMR directly measures through-plane flow without geometric assumptions and shows excellent agreement with invasive oximetry (the true gold standard).

CMR Advantages Over Echo:

  • No geometric assumptions required
  • Multiple internal quality checks possible (can measure at pulmonary trunk, aorta, pulmonary veins, or vena cavae)
  • Simultaneous assessment of ventricular volumes and function
  • Better anatomic delineation of complex/multiple VSDs 1

Special Consideration for VSD

In VSD specifically, left ventricular stroke volume will be twice the right ventricular stroke volume when Qp/Qs = 2:1 (opposite of ASD), so shunt location must be known when using ventricular volumes 1.

Clinical Context

While echocardiography remains the first-line anatomic evaluation tool for VSD 1, for hemodynamically significant decisions requiring accurate Qp/Qs quantification, proceed directly to CMR rather than relying on echocardiographic estimates. The LVIV/LVOV ratio method can provide screening information (values >1.4 suggest Qp/Qs >2:1 2, 3), but definitive management decisions warrant CMR confirmation.

Invasive catheterization with oximetry remains indicated only when pulmonary artery pressure and pulmonary vascular resistance measurements are simultaneously required (e.g., suspected Eisenmenger physiology) 1.

References

Related Questions

In a patient with a palpable thrill and a grade V holosystolic murmur due to a ventricular septal defect, are peripheral pulses expected to be normal or bounding?
What are the typical findings on a two-dimensional transthoracic echocardiogram in a patient with a ventricular septal defect?
What are the recommendations for pregnancy in a woman with a ventricular septal defect (VSD), including pre‑conception evaluation, cardiac monitoring during gestation, and delivery management?
What medications are recommended for symptomatic ventricular septal defect (VSD) in infants or children, including dosing and monitoring?
How should a small restrictive ventricular septal defect be managed in an asymptomatic 7‑year‑old child?
Can the amlodipine dose be increased from 5 mg to 10 mg daily in a patient whose blood pressure is 180/96 mm Hg after 5 days of therapy?
Can you interpret the right shoulder X‑ray of a patient presenting with shoulder pain, which shows no acute fracture or dislocation, the humeral head correctly positioned in the glenoid, mild degenerative changes of the right acromioclavicular and glenohumeral joints with joint‑space narrowing and osteophyte formation, and diffuse osteopenia?
When should a patient be referred to a nephrologist for a low estimated glomerular filtration rate (eGFR)?
What weight‑loss medication regimen is recommended for a patient with a history of gastritis and esophagitis?
What is the most appropriate medication for conjunctivitis?
In a patient with positive antinuclear antibody (ANA) and anti‑RNP antibodies, what is the most likely diagnosis and the recommended next diagnostic and therapeutic steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.